Excellence in Hemoglobinopathies Research Award Program
Page 2

It is the hope of the NHLBI that the proposals will pave the way to several interdisciplinary approaches to translational research in the hemoglobinopathies, which entails a higher likelihood of high-impact research eventually becoming applied clinical research studies.

The end goal of the studies that will be proposed under this project is centered on the discovery of small molecules, biologics, and biomarkers that can all be utilized in the process of diagnosing, treating, and managing sickle cell disease or the thalassemias.

The NHLBI is set to administer 7 to 10 grant awards with an overall budget of $72.85, with a total cost of $14 million for the year 2013 alone.

The organizations and institutions that will be deemed eligible to submit an application under the Excellence in Hemoglobinopathies Research Award Program are the following:

a) Higher Education Institutions such as Public/State Controlled Institutions of Higher Education and Private Institutions of Higher Education

b) Nonprofits Other Than Institutions of Higher Education

c) For-Profit Organizations such as Small Businesses and other organizations other than Small Businesses

d) State Governments, County Governments, City or Township Governments and Special District Governments

e) Independent School Districts, Public Housing Authorities/Indian Housing Authorities, Native American Tribal Organizations (other than Federally recognized tribal governments), Faith-based or Community-based Organizations, and Regional Organizations.

Excellence in Hemoglobinopathies Research Award Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on artist grants and children grants.

Additional Resources

category - Health Grants

Critical Congenital Heart Disease Newborn Screening Demonstration Program
The Health Resources and Services Administration has recently constituted the Critical Congenital Heart Disease (CCHD) Newborn Screening Demonstration Program in order to support and encourage the development, dissemination, and validation of screening protocols and newborn screening infrastructure for point of care screenings that are specific to Critical Congenital Heart Diseases.

---

Leadership Group for a Clinical Research Network on Antibacterial Resistance Program
In line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program.

---

National Institutes of Health funds the Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults
The National Institutes of Health has recently established a program entitled Improving Adherence to Treatment Regimens for HIV-Positive Adolescents and Young Adults wherein they intend to kick-off research studies that will create, implement, and evaluate both old and new interventions that are geared towards improving adherence to medical and behavioral regimens for HIV-positive adolescents which are 11 to 21 years old and adults who are 21 to 24 years old.

---

Exploratory Clinical Trials for Small Business Grant Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they aim to establish a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NIND

---